News & Events

Recent News View All News

Jan 27, 2023 7:00am EST

Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion

Dec 20, 2022 7:00am EST

Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE

Recent Events View IR Calendar

Dec 5, 2022 2:00 pm EST

RHK 2022 Disruptive Growth Conference

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings